Money moves in silence. Download 2025 State of Venture Report: a data-driven analysis of active funds, unicorn, and family offices
About usSign in

Frazier Life Sciences

Status
Active
Global HQ
California, United States
Countries of investment
  • United States
  • Canada
  • Europe
Investment stages
  • Seed
  • Series A
  • Series B
Industries
  • Biotech
About
Frazier Life Sciences (part of Frazier Healthcare Partners) is a biotech VC based in Seattle, leading highly curated investments in therapeutics with significant track record in creating and scaling firms.
Min check size
$100K
Max check size
$1M
Fund size
NPS

Investment Thesis

Invests in novel therapeutic companies—from company creation through Series A/B—focused on transformative life sciences.
Lead investor
Co Invest
Number of exits
Preferred contact method

Frazier Life Sciences Contacts Information

Primary contact

Secondary contact

Team

Albert Cha, M.D., Ph.D. – Managing Partner; James N. Topper, M.D., Ph.D. – Managing Partner; Patrick Heron – Managing Partner; Daniel Estes, Ph.D. – General Partner; James W. Brush, M.D. – General Partner & Portfolio Manager; Anna H. Chen, Ph.D. – Partner; Aditya Kohli, Ph.D. – Partner; Joe Cabral – Principal; Kevin Li, M.D. – Principal; Lin Mu, M.D., MBA – Vice President; Angel Martin, Ph.D. – Senior Associate; Jason Wang – Senior Associate; Kiah Williams, M.D. – Senior Associate; Xinghuo Li, Ph.D. – Associate; Chris Wittenborn – Trader; Gordon Empey – Chief Operating Officer, General Counsel and Partner; Ali Jackson – Vice President and Counsel, Public Funds; Ailsa Dalgliesh, Ph.D. – Head of Investor Relations; Kei Nakazono – IT Director; Shu Yeung – Director, Human Resources; Adam Simpson – Venture Partner; James Li, M.D. – Venture Partner; Maria Fardis, Ph.D. – Venture Partner; Mitch Gold, M.D. – Venture Partner; Robert Hershberg, M.D., Ph.D. – Venture Partner; Stanford Peng, M.D., Ph.D. – Venture Partner; Tao Fu, M.D., Ph.D. – Venture Partner; Azmi Nabulsi, M.D., M.P.H. – Entrepreneur‑in‑Residence; Brian Farmer – Entrepreneur‑in‑Residence; Chris Peetz – Entrepreneur‑in‑Residence; Gordon McMurray, Ph.D. – Entrepreneur‑in‑Residence; Ian W. Mills, B.M., B.CH., D.M. – Entrepreneur‑in‑Residence; Scott Byrd – Entrepreneur‑in‑Residence; Lauren Mifflin, Ph.D. – Principal of Company Creation; Christopher Aakre, Ph.D. – Principal of Company Creation; Zaneta Odrowaz, Ph.D. – Vice President of Company Creation; Alan Frazier – Chairman Emeritus; Angie You, Ph.D. – Senior Advisor; Bhaskar Chaudhuri, Ph.D. – Senior Advisor; Scott Wasserman, M.D. – Venture Partner; James Li, M.D. – Venture Partner

Portfolio

Arcutis Biotherapeutics

Phathom Pharmaceuticals

Lengo Therapeutics

Amunix Pharmaceuticals

Acerta Pharma

Krystal Biotech

Chinook Therapeutics

Sierra Oncology

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp